We specialize in developing novel diagnostics that are better quantitative indicators of the inflammatory response in infectious and chronic diseases (such as SARS-CoV-2, Dengue fever, rheumatoid arthritis, inflammatory bowel disease, and others) to determine the right course of treatment, improve efficacy of care and thereby save more patient lives.
Inflammation is a silent killer
According to the CDC, 8 out of 10 cardiac events and deaths can be prevented. Early risk assessment is key for prevention.
We need a better way to identify chronic inflammation early – because underlying inflammation (often currently undiagnosed) is a serious problem leading to many chronic disease states, including:
•Alzheimer's and other dementias